2013 Executive Officer Compensation Arrangements
EX-10.6 2 jazzq12013ex106.htm JAZZ PHARMACEUTICALS PLC 2013 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS JAZZ Q1 2013 EX 10.6
Exhibit 10.6
2013 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $775,000 | 100 |
Kathryn E. Falberg Executive Vice President and Chief Financial Officer | $475,000 | 50 |
Russell J. Cox Executive Vice President and Chief Commercial Officer | $425,000 | 50 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $475,000 | 50 |
Fintan Keegan Executive Vice President, Technical Operations | €270,000 | 50 |
Jeffrey K. Tobias, M.D. Executive Vice President, Research and Development and Chief Medical Officer | $425,000 | 50 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $285,000 | 40 |
(1) | Base salary rate effective beginning by March 1, 2013. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |
